1. Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
    Xianyong Zhou et al, 2023, Molecular Cancer CrossRef
  2. The synergistic effect of mefenamic acid with ionizing radiation in colon cancer
    Seyed Jalal Hosseinimehr et al, 2019, Journal of Bioenergetics and Biomembranes CrossRef
  3. Two isostructural Co(II) flufenamato and niflumato complexes with bathocuproine: Analogues with a different cytotoxic activity
    Lukáš Smolko et al, 2020, Journal of Inorganic Biochemistry CrossRef
  4. Butein induces apoptotic cell death of human cervical cancer cells
    Pei‑Yu Yang et al, 2018, Oncology Letters CrossRef
  5. Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
    Medi Kori et al, 2022, Frontiers in Pharmacology CrossRef
  6. Proteomics analysis of meclofenamic acid‐treated small cell lung carcinoma cells revealed changes in cellular energy metabolism for cancer cell survival
    Sevinc Yanar et al, 2023, Journal of Biochemical and Molecular Toxicology CrossRef
  7. Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique
    Mona A. Shewaiter et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
  8. Synergistic effect of a nonsteroidal anti-inflammatory drug in combination with topotecan on small cell lung cancer cells
    Sevinc Yanar et al, 2024, Molecular Biology Reports CrossRef
  9. Potential drug targets against HPV and repurposing of existing drugs
    Utkarsha Sahu et al, 2022, Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies CrossRef
  10. The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells
    Aline Kowalski-Chauvel et al, 2020, Cancers CrossRef
  11. Different effects of the nonsteroidal anti-inflammatory drugs meclofenamate sodium and naproxen sodium on proteasome activity in cardiac cells
    Rajeshwary Ghosh et al, 2016, Journal of Molecular and Cellular Cardiology CrossRef
  12. Meclofenamic acid inhibits the invasion and migration of LNCaP prostate carcinoma cells by regulating vimentin expression
    Aylin KANLI et al, 2022, Acta Medica Nicomedia CrossRef
  13. Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
    Bowen Li et al, 2020, Drug Resistance Updates CrossRef
  14. Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis
    Biqing Chen et al, 2023, Archives of Biochemistry and Biophysics CrossRef

  15. Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid


    Zhuo-Yue Li et al, 2020, International Journal of Nanomedicine CrossRef
  16. Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity
    Azza El-Sheikh et al, 2021, Medicina CrossRef
  17. Hollow Magnetic Iron Oxide Nanoparticles as Sodium Meclofenamate Drug Delivery Systems
    Méndez-Rojas Miguel A, 2016, Journal of Nanomedicine Research CrossRef
  18. Antitumor Effects of Annopurpuricin A, an Acetogenin from the Roots of Annona purpurea
    Gustavo A. Hernández-Fuentes et al, 2023, Revista Brasileira de Farmacognosia CrossRef
  19. Decreased biochemical progression in patients with castration‑resistant prostate cancer using a novel mefenamic acid anti‑inflammatory therapy: A randomized controlled trial
    Jos� Guzman‑Esquivel et al, 2020, Oncology Letters CrossRef
  20. Mechanistic Insight for Targeting Biomolecules by Ruthenium(II) NSAID Complexes
    Chanchal Sonkar et al, 2020, ACS Applied Bio Materials CrossRef
  21. The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics
    Janice García-Quiroz et al, 2022, Cells CrossRef